In conclusion, our data provide novel insight on the role of miR-3148-SMAD2-TGFβ axis during malignant transformation of hMSCs into sarcoma-like cancer and suggest therapeutic approaches targeting miR-3148/SMAD2/TGFβ pathway as plausible therapeutic strategy. The gene discussed is SMAD2; the disease is cancer.